2980 Results for "

Interaction

" in MedChemExpress (MCE) Product Catalog:
Products (2980)

2980 Results for "Interaction" in MCE Product Catalog:

20
20 Cited Publications
Cat. No.: HY-119706
CAS No.: 356568-70-2
Purity:  98.93%
Target:  

Apoptosis Arrestin

Research Areas:  

Others

Barbadin is a novel and selective β-arrestin/β2-adaptin interaction inhibitor, has IC50 values of 19.1 μM for β-arrestin1 and 15.6 μM for β-arrestin2. Barbadin blocks agonist-promoted endocytosis of the prototypical β2-adrenergic, V2-vasopressin and angiotensin-II type-1 receptors. Barbadin can induce apoptosis .
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-W127378
CAS No.: 144189-73-1
Synonyms: 1,2-Dioleoyl-3-trimethylammonium-propane methylsulfate
Target:  

Liposome

Research Areas:  

Others

DOTAP methylsulfat is a cationic lipid reagent, a cationic derivative of trimethylammonium, linked to two 18-carbon fatty acid tails, each with a single olefin group. DOTAP methylsulfat can self-assemble with negatively charged ions (such as DNA) to form complexes, which can be adsorbed to the cell membrane surface and enter the cell by electrostatic interaction and endocytosis, respectively. DOTAP methylsulfat promotes endosomal membrane fusion with its own hydrophobic domain, releases DNA into the cytoplasm, and exerts gene delivery function. DOTAP methylsulfat can be widely used in research fields such as gene therapy, cell transfection, and non-viral vector design .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-A0036
CAS No.: 198481-33-3
Synonyms: TSE-424 acetate
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Bazedoxifene acetate (TSE-424 acetate) is an oral, nonsteroidal selective estrogen receptor modulator (SERM), with IC50s of 23 nM and 99 nM for ERα and ERβ, respectively. Bazedoxifene acetate can be used for the research of osteoporosis. Bazedoxifene acetate also acts as an inhibitor of IL-6/GP130 protein-protein interactions and can be used for the research of pancreatic cancer .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-A0031
CAS No.: 198481-32-2
Synonyms: TSE-424
Target:  

Estrogen Receptor/ERR

Research Areas:  

Neurological Disease Cancer

Bazedoxifene (TSE-424) is an oral, BBB-penetrant nonsteroidal selective estrogen receptor modulator (SERM), with IC50s of 23 nM and 99 nM for ERα and ERβ, respectively. Bazedoxifene can be used for the research of osteoporosis. Bazedoxifene also acts as an inhibitor of IL-6/GP130 protein-protein interactions and can be used for the research of pancreatic cancer .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-P0118
CAS No.: 272105-42-7
Synonyms: P144
Research Areas:  

Cancer

Disitertide (P144) is a peptidic transforming growth factor-beta 1 (TGF-β1) inhibitor specifically designed to block the interaction with its receptor. Disitertide (P144) is also a PI3K inhibitor and an apoptosis inducer .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-P0118B
Synonyms: P144 diammonium
Research Areas:  

Cancer

Disitertide (P144) diammonium is a peptidic transforming growth factor-beta 1 (TGF-β1) inhibitor specifically designed to block the interaction with its receptor. Disitertide diammonium is also a PI3K inhibitor and an apoptosis inducer .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-19831
CAS No.: 315706-13-9
4EGI-1 is an inhibitor of eIF4E/eIF4G interaction, with a Kd of 25 μM against eIF4E binding.
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-100947
CAS No.: 2097381-85-4
Purity:  99.54%
VH-298 is a highly potent inhibitor of the VHL:HIF-α interaction with a Kd value of 80 to 90 nM. VH-298 leads to HIF-α accumulation inside HeLa cells. VH-298 is an E3 ligase Ligand, and can be used for synthesis of PROTACs .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-148439
CAS No.: 2765081-21-6
Purity:  99.68%
Synonyms: RMC-6236; RAS-IN-2
Target:  

Ras PERK

Research Areas:  

Cancer

Daraxonrasib (RMC-6236) is an orally active, non-covalent RAS (ON) inhibitor. Daraxonrasib disrupts the interaction of wild-type or mutant RAS proteins with the RAS binding domain of BRAF, with EC50 values ranging from 28-220 nM for wild-type KRAS, NRAS, HRAS, and multiple oncogenic RAS variants. Daraxonrasib inhibits pERK. Daraxonrasib has anti-tumor activity against KRAS mutant tumors .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-111374
CAS No.: 307519-88-6
Purity:  99.68%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

NMDI14 is a nonsense mediated RNA decay (NMD) inhibitor. NMDI14 disrupts the SMG7-UPF1 interactions and inhibits NMD.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-16993
CAS No.: 1801787-56-3
Target:  

Apoptosis WDR5

Research Areas:  

Cancer

OICR-9429, a chemical probe, is high affinity WD repeat domain 5 (WDR5) inhibitor, competitively blocks WDR5 interaction with MLL protein via binding the central peptide-binding pocket of WDR5. OICR-9429 can suppress histone H3K4 trimethylation and can be used for the research of various cancers including non-MLL-rearranged leukaemia, colon, pancreatic, prostate cancer and bladder cancer (BCa) .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-116961
CAS No.: 1841460-82-9
Purity:  99.81%
TH1020 is a potent and selective toll-like receptor 5 (TLR5)/flagellin complex antagonist with an IC50 of 0.85 μM. TH1020 inhbits flagellin-induced TLR5 signaling. TH1020 is inactive against TLR2, TLR3, TLR4, TLR7 and TLR8 .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-101486
CAS No.: 664969-54-4
Purity:  99.55%
Target:  

β-catenin

Research Areas:  

Cancer

LF3 is an antagonist of the β-Catenin/TCF4 interaction with antitumor activity; has an IC50 of 1.65 μM .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-12404
CAS No.: 908-54-3
Purity:  99.16%
Synonyms: Diminazene diaceturate
Diminazene aceturate (Diminazene diaceturate) is an anti-trypanosome agent for livestock. The main biochemical mechanism of the trypanocidal actions of Diminazene aceturate is by binding to trypanosomal kinetoplast DNA (kDNA) in a non-intercalative manner through specific interaction with sites rich in adenine-thymine base pairs. Diminazene aceturate is also an angiotensin-converting enzyme 2 (ACE2) activator and has strong and potent anti-inflammatory properties .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-108470
CAS No.: 30195-30-3
Purity:  99.35%
Target:  

RUNX

Research Areas:  

Cancer

Ro5-3335, a benzodiazepine, acts as an inhibitor of core binding factor (CBF) leukemia. Ro5-3335 is a RUNX1-CBFβ interaction inhibitor that represses RUNX1/CBFB-dependent transactivation .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-108473
CAS No.: 1279713-77-7
Purity:  99.34%
Synonyms: TLR3-IN-1
Research Areas:  

Cancer

CU-CPT 4a (TLR3-IN-1) is a potent, highly selective TLR3 signaling inhibitor. CU-CPT 4a represses the expression of downstream signaling pathways mediated by the TLR3/dsRNA complex, including TNF-α and IL-1β .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-114162
CAS No.: 2169916-18-9
Purity:  99.69%
Synonyms: SNDX-50469
Research Areas:  

Cancer

VTP50469 is a potent, highly selective and orally active Menin-MLL interaction inhibitor with a Ki of 104 pM. VTP50469 has potently anti-leukemia activity .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-114162A
CAS No.: 2169919-29-1
Purity:  99.79%
Synonyms: SNDX-50469 fumarate
Research Areas:  

Cancer

VTP50469 fumarate is a potent, highly selective and orally active Menin-MLL interaction inhibitor with a Ki of 104 pM. VTP50469 fumarate has potently anti-leukemia activity .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-117282
CAS No.: 1456551-16-8
Purity:  99.88%
Target:  

HSP Apoptosis

Research Areas:  

Cancer

JG-98, an allosteric heat shock protein 70 (Hsp70) inhibitor, which binds tightly to a conserved site on Hsp70 and disrupts the Hsp70-Bag3 interaction. JG-98 shows anti-cancer activities affecting both cancer cells and tumor-associated macrophages .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-136453
CAS No.: 1352914-52-3
Purity:  98.38%
Research Areas:  

Cancer

CR-1-31-B is a synthetic rocaglate and a potent eIF4A inhibitor. CR-1-31-B exhibits powerful inhibitory effects over eIF4A by perturbing the interaction between eIF4A and RNA, sequentially impeding initiation during protein synthesis. CR-1-31-B perturbs association of Plasmodium falciparum eIF4A (PfeIF4A) with RNA. CR-1-31-B induces apoptosis of neuroblastoma and gallbladder cancer cells .
loading...
    loading...